Lung Cancer Screening Disparity: Only 23% Eligible Get Screened
Locales: Wisconsin, UNITED STATES

Green Bay, WI - March 8th, 2026 - A recent study published in JAMA Network Open has revealed a concerning disparity between the number of Americans eligible for lung cancer screening and those actually receiving it. The findings indicate that less than a quarter (approximately 23%) of individuals meeting the recommended criteria are undergoing this potentially life-saving preventative measure. This stark statistic underscores a critical public health challenge, highlighting a need for increased awareness, improved accessibility, and a re-evaluation of current healthcare practices.
Lung cancer remains the leading cause of cancer-related deaths in the United States, accounting for a significant portion of all cancer fatalities annually. Early detection is paramount in improving treatment outcomes and survival rates. Low-dose computed tomography (LDCT) scans are the recommended screening method for individuals at high risk, primarily those with a history of smoking or who have quit relatively recently. These scans can identify tumors at an earlier stage, when they are more amenable to treatment, potentially leading to a cure or significantly extending a patient's life.
Dr. Christine Annunzio, a pulmonologist with Prevea Health, emphasizes the importance of screening. "We know lung cancer is the leading cause of cancer deaths in the United States," she explained. "Screening can help catch it earlier, when it's more treatable." The current guidelines, established by organizations like the U.S. Preventive Services Task Force, recommend annual LDCT scans for individuals aged 50-80 with a 20 pack-year smoking history - meaning they've smoked the equivalent of one pack a day for 20 years - and who currently smoke or have quit within the past 15 years. Despite these clear recommendations, uptake remains alarmingly low.
The reasons behind this low screening rate are complex and multifaceted. Researchers point to a confluence of factors, including a lack of awareness among both the public and healthcare providers, logistical and financial barriers to access, and a degree of hesitancy from both patients and physicians. Many individuals are simply unaware that they are eligible for screening or that it can significantly improve their chances of survival. Others may be deterred by concerns about the cost of the procedure, the need for transportation to a screening facility, or anxiety about potential false positives or radiation exposure (although the radiation dose from LDCT scans is relatively low).
Physician hesitancy also plays a role. Some doctors may not be fully informed about the latest screening guidelines or may harbor concerns about the potential for overdiagnosis and overtreatment. Ensuring that primary care physicians are well-versed in the benefits and risks of lung cancer screening is crucial. Effective communication strategies can equip them with the knowledge and tools to confidently discuss screening options with their at-risk patients.
Addressing these barriers requires a comprehensive, multi-pronged approach. Public health campaigns are needed to raise awareness about lung cancer screening and educate individuals about their eligibility. These campaigns should target high-risk populations, including current and former smokers, and emphasize the potential benefits of early detection. Increased access to screening services is also essential. This could involve expanding screening programs in underserved communities, offering mobile screening units, and reducing the financial burden on patients through insurance coverage and financial assistance programs.
Furthermore, integrating lung cancer screening into routine primary care visits could significantly improve participation rates. Reminders, decision aids, and collaborative discussions between physicians and patients can help overcome hesitancy and encourage informed decision-making. The American Cancer Society ([ https://www.cancer.org/ ]) provides a wealth of information about lung cancer screening, including eligibility criteria, screening locations, and financial resources. Utilizing these resources can empower individuals to take proactive steps towards protecting their health.
The study's authors advocate for a concerted effort to improve lung cancer screening rates. While challenges undoubtedly exist, prioritizing this preventative measure is a vital step in reducing the devastating impact of this deadly disease. Closing the gap between eligibility and participation will require collaboration between healthcare providers, public health organizations, policymakers, and individuals themselves. Ultimately, increasing screening rates will not only save lives but also improve the quality of life for countless Americans affected by lung cancer.
Read the Full WBAY Article at:
[ https://www.wbay.com/2026/02/23/most-americans-eligible-lung-cancer-screening-arent-getting-tested-study-finds/ ]